Ashrafizadeh, MiladMohan, Chakrabhavi D.Rangappa, ShobithZarrabi, AliHushmandi, KiavashKumar, Alan PremSethi, Gautam2024-05-192024-05-1920230198-63251098-1128https://doi.org10.1002/med.21950https://hdl.handle.net/20.500.12713/4907Gastrointestinal (GI) tumors (cancers of the esophagus, gastric, liver, pancreas, colon, and rectum) contribute to a large number of deaths worldwide. STAT3 is an oncogenic transcription factor that promotes the transcription of genes associated with proliferation, antiapoptosis, survival, and metastasis. STAT3 is overactivated in many human malignancies including GI tumors which accelerates tumor progression, metastasis, and drug resistance. Research in recent years demonstrated that noncoding RNAs (ncRNAs) play a major role in the regulation of many signaling pathways including the STAT3 pathway. The major types of endogenous ncRNAs that are being extensively studied in oncology are microRNAs, long noncoding RNAs, and circular RNAs. These ncRNAs can either be tumor-promoters or tumor-suppressors and each one of them imparts their activity via different mechanisms. The STAT3 pathway is also tightly modulated by ncRNAs. In this article, we have elaborated on the tumor-promoting role of STAT3 signaling in GI tumors. Subsequently, we have comprehensively discussed the oncogenic as well as tumor suppressor functions and mechanism of action of ncRNAs that are known to modulate STAT3 signaling in GI cancers.eninfo:eu-repo/semantics/closedAccessCircrnaColorectal CancerEsophageal CancerGastric CancerLiver CancerLncrnaMirnaPancreatic CancerReview Article4351263132136951271WOS:0009550929000012-s2.0-85151000323N/A10.1002/med.21950Q1